US Stock MarketDetailed Quotes

JSPR Jasper Therapeutics

Watchlist

21.270
+0.090+0.42%

Close Nov 1 16:00 ET

321.29MMarket Cap-4170P/E (TTM)

Jasper Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

12.00%-11.68M

-52.26%-15.74M

-13.54%-52.07M

-30.31%-16.48M

-24.25%-11.98M

-41.86%-13.27M

27.28%-10.34M

-36.17%-45.86M

13.29%-12.65M

-35.66%-9.64M

Net income from continuing operations

9.31%-14.58M

3.73%-13.73M

-71.06%-64.47M

-25.51%-16.58M

-47.89%-17.54M

-54.56%-16.08M

-546.13%-14.26M

-23.00%-37.69M

-45.87%-13.21M

-247.68%-11.86M

Operating gains losses

----

107.99%575K

--0

109.50%575K

-339.92%-7.2M

-200.00%-150K

65.56%-155K

Depreciation and amortization

8.73%299K

5.11%288K

13.64%1.11M

3.66%283K

2.99%276K

26.15%275K

26.85%274K

158.62%975K

40.72%273K

103.03%268K

Other non cash items

137.74%120K

-84.24%136K

107.44%401K

833.33%84K

31.33%-228K

40.00%-318K

119.02%863K

40.69%-5.39M

100.30%9K

94.69%-332K

Change In working capital

-31.37%1M

-480.66%-3.6M

886.29%5.1M

-21.52%-1.42M

129.53%4.12M

28.07%1.46M

139.20%946K

-140.04%-649K

59.44%-1.17M

-33.12%1.8M

-Change in receivables

--0

200.00%663K

--0

--663K

-210.50%-663K

---663K

--0

-Change in prepaid assets

-107.93%-28K

175.17%218K

145.83%767K

48.42%-700K

38.87%1.4M

-61.92%353K

-7.81%-290K

114.10%312K

29.54%-1.36M

162.60%1.01M

-Change in payables and accrued expense

-4.46%1.01M

-560.71%-3.51M

495.59%5.2M

223.10%469K

205.87%2.92M

488.83%1.05M

136.82%761K

-133.74%-1.32M

3.54%-381K

-37.57%954K

-Change in other current assets

-7.14%260K

-335.29%-80K

-412.28%-584K

-331.48%-932K

0.00%34K

723.53%280K

0.00%34K

67.15%-114K

37.75%-216K

-94.92%34K

-Change in other current liabilities

-4.41%-237K

-4.95%-233K

-183.55%-945K

-117.98%-260K

-15.69%-236K

---227K

-100.00%-222K

456.78%1.13M

760.27%1.45M

-300.00%-204K

Cash from discontinued investing activities

Operating cash flow

12.00%-11.68M

-52.26%-15.74M

-13.54%-52.07M

-30.31%-16.48M

-24.25%-11.98M

-41.86%-13.27M

27.28%-10.34M

-36.17%-45.86M

13.29%-12.65M

-35.66%-9.64M

Investing cash flow

Cash flow from continuing investing activities

-1,327.27%-157K

3.85%-25K

53.65%-267K

-180.49%-230K

95.47%-11K

10.34%-26K

76.28%-576K

88.47%-82K

52.77%-222K

Net PPE purchase and sale

-1,327.27%-157K

3.85%-25K

53.65%-267K

-180.49%-230K

--0

95.47%-11K

10.34%-26K

76.28%-576K

88.47%-82K

52.77%-222K

Cash from discontinued investing activities

Investing cash flow

-1,327.27%-157K

3.85%-25K

53.65%-267K

-180.49%-230K

--0

95.47%-11K

10.34%-26K

76.28%-576K

88.47%-82K

52.77%-222K

Financing cash flow

Cash flow from continuing financing activities

159.34%181K

-53.36%47.35M

183,483.64%100.97M

-1,067.86%-271K

3,500.00%36K

-2,446.15%-305K

780,753.85%101.51M

-99.95%55K

103.08%28K

-100.00%1K

Net common stock issuance

--0

-53.49%47.2M

--101.48M

--0

--101.48M

--0

Proceeds from stock option exercised by employees

-49.16%181K

381.25%154K

721.82%452K

0.00%28K

3,500.00%36K

2,638.46%356K

146.15%32K

-76.69%55K

-17.65%28K

-99.24%1K

Net other financing activities

----

---960K

---299K

--0

----

Cash from discontinued financing activities

Financing cash flow

159.34%181K

-53.36%47.35M

183,483.64%100.97M

-1,067.86%-271K

3,500.00%36K

-2,446.15%-305K

780,753.85%101.51M

-99.95%55K

103.08%28K

-100.00%1K

Net cash flow

Beginning cash position

-8.42%118.89M

125.78%87.3M

-54.53%38.67M

103.02%104.28M

89.82%116.23M

83.31%129.82M

-54.53%38.67M

321.37%85.05M

-49.27%51.37M

258.03%61.23M

Current changes in cash

14.22%-11.66M

-65.35%31.59M

204.87%48.64M

-33.70%-16.98M

-21.10%-11.95M

-41.75%-13.59M

740.59%91.15M

-171.50%-46.38M

21.62%-12.7M

-111.72%-9.86M

End cash Position

-7.74%107.24M

-8.42%118.89M

125.78%87.3M

103.02%104.28M

89.82%116.23M

83.31%129.82M

-54.53%38.67M

-49.27%51.37M

Free cash flow

10.89%-11.84M

-52.12%-15.76M

-12.71%-52.33M

-31.28%-16.71M

-21.45%-11.98M

-38.38%-13.28M

27.25%-10.36M

-28.60%-46.43M

16.78%-12.73M

-30.18%-9.87M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	12.00%-11.68M	-52.26%-15.74M	-13.54%-52.07M	-30.31%-16.48M	-24.25%-11.98M	-41.86%-13.27M	27.28%-10.34M	-36.17%-45.86M	13.29%-12.65M	-35.66%-9.64M
Net income from continuing operations	9.31%-14.58M	3.73%-13.73M	-71.06%-64.47M	-25.51%-16.58M	-47.89%-17.54M	-54.56%-16.08M	-546.13%-14.26M	-23.00%-37.69M	-45.87%-13.21M	-247.68%-11.86M
Operating gains losses	----	----	107.99%575K	--0	--0	--0	109.50%575K	-339.92%-7.2M	-200.00%-150K	65.56%-155K
Depreciation and amortization	8.73%299K	5.11%288K	13.64%1.11M	3.66%283K	2.99%276K	26.15%275K	26.85%274K	158.62%975K	40.72%273K	103.03%268K
Other non cash items	137.74%120K	-84.24%136K	107.44%401K	833.33%84K	31.33%-228K	40.00%-318K	119.02%863K	40.69%-5.39M	100.30%9K	94.69%-332K
Change In working capital	-31.37%1M	-480.66%-3.6M	886.29%5.1M	-21.52%-1.42M	129.53%4.12M	28.07%1.46M	139.20%946K	-140.04%-649K	59.44%-1.17M	-33.12%1.8M
-Change in receivables	--0	--0	200.00%663K	--0	--0	--0	--663K	-210.50%-663K	---663K	--0
-Change in prepaid assets	-107.93%-28K	175.17%218K	145.83%767K	48.42%-700K	38.87%1.4M	-61.92%353K	-7.81%-290K	114.10%312K	29.54%-1.36M	162.60%1.01M
-Change in payables and accrued expense	-4.46%1.01M	-560.71%-3.51M	495.59%5.2M	223.10%469K	205.87%2.92M	488.83%1.05M	136.82%761K	-133.74%-1.32M	3.54%-381K	-37.57%954K
-Change in other current assets	-7.14%260K	-335.29%-80K	-412.28%-584K	-331.48%-932K	0.00%34K	723.53%280K	0.00%34K	67.15%-114K	37.75%-216K	-94.92%34K
-Change in other current liabilities	-4.41%-237K	-4.95%-233K	-183.55%-945K	-117.98%-260K	-15.69%-236K	---227K	-100.00%-222K	456.78%1.13M	760.27%1.45M	-300.00%-204K
Cash from discontinued investing activities
Operating cash flow	12.00%-11.68M	-52.26%-15.74M	-13.54%-52.07M	-30.31%-16.48M	-24.25%-11.98M	-41.86%-13.27M	27.28%-10.34M	-36.17%-45.86M	13.29%-12.65M	-35.66%-9.64M
Investing cash flow
Cash flow from continuing investing activities	-1,327.27%-157K	3.85%-25K	53.65%-267K	-180.49%-230K	0	95.47%-11K	10.34%-26K	76.28%-576K	88.47%-82K	52.77%-222K
Net PPE purchase and sale	-1,327.27%-157K	3.85%-25K	53.65%-267K	-180.49%-230K	--0	95.47%-11K	10.34%-26K	76.28%-576K	88.47%-82K	52.77%-222K
Cash from discontinued investing activities
Investing cash flow	-1,327.27%-157K	3.85%-25K	53.65%-267K	-180.49%-230K	--0	95.47%-11K	10.34%-26K	76.28%-576K	88.47%-82K	52.77%-222K
Financing cash flow
Cash flow from continuing financing activities	159.34%181K	-53.36%47.35M	183,483.64%100.97M	-1,067.86%-271K	3,500.00%36K	-2,446.15%-305K	780,753.85%101.51M	-99.95%55K	103.08%28K	-100.00%1K
Net common stock issuance	--0	-53.49%47.2M	--101.48M	--0	--0	--0	--101.48M	--0	--0	--0
Proceeds from stock option exercised by employees	-49.16%181K	381.25%154K	721.82%452K	0.00%28K	3,500.00%36K	2,638.46%356K	146.15%32K	-76.69%55K	-17.65%28K	-99.24%1K
Net other financing activities	----	----	---960K	---299K	--0	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	159.34%181K	-53.36%47.35M	183,483.64%100.97M	-1,067.86%-271K	3,500.00%36K	-2,446.15%-305K	780,753.85%101.51M	-99.95%55K	103.08%28K	-100.00%1K
Net cash flow
Beginning cash position	-8.42%118.89M	125.78%87.3M	-54.53%38.67M	103.02%104.28M	89.82%116.23M	83.31%129.82M	-54.53%38.67M	321.37%85.05M	-49.27%51.37M	258.03%61.23M
Current changes in cash	14.22%-11.66M	-65.35%31.59M	204.87%48.64M	-33.70%-16.98M	-21.10%-11.95M	-41.75%-13.59M	740.59%91.15M	-171.50%-46.38M	21.62%-12.7M	-111.72%-9.86M
End cash Position	-7.74%107.24M	-8.42%118.89M	125.78%87.3M	125.78%87.3M	103.02%104.28M	89.82%116.23M	83.31%129.82M	-54.53%38.67M	-54.53%38.67M	-49.27%51.37M
Free cash flow	10.89%-11.84M	-52.12%-15.76M	-12.71%-52.33M	-31.28%-16.71M	-21.45%-11.98M	-38.38%-13.28M	27.25%-10.36M	-28.60%-46.43M	16.78%-12.73M	-30.18%-9.87M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data